Learn More
Invitrogen™ E-Cadherin Monoclonal Antibody (4A2C7)

Description
This monoclonal antibody reacts with human epithelial cadherin (E-cadherin, uvomorulin, Cell-CAM 120/80), a 120 kDa transmembrane glycoprotein. Reduction and/or loss of E-cadherin expression in carcinomas correlates positively with tumor cell invasion and metastasis. Altered expression of E-cadherin is common in the progression of cancers including breast carcinoma, lung carcinoma, gastric tumors, hepatocellular carcinoma, and prostatic tumors. It has recently been reported that E-cadherin is a useful marker for differentiating lobular lesions (negative) from ductal invasive lesions (positive) in breast cancer. Positive tissue: Non-neural epithelia. Reacts strongly with human E-cadherin and weakly with human P-cadherin. Expected Staining Pattern: Mainly cellular membrane, some cytoplasmic.
Specifications
Specifications
| Antigen | E-Cadherin |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Monoclonal |
| Clone | 4A2C7 |
| Conjugate | Unconjugated |
| Dilution | Concentrate Antibody |
| Formulation | PBS with 1% BSA and 0.1% sodium azide |
| Gene | CDH1 |
| Gene Accession No. | P12830 |
| Gene Alias | AA960649; ARC-1; cadherin 1; cadherin 1, E-cadherin (epithelial); cadherin 1, epithelial; cadherin 1, type 1; cadherin 1, type 1, E-cadherin (epithelial); cadherin e; cadherin-1; cadherin-E; calcium-dependent adhesion protein, epithelial; CAM 120/80; CD324; CDH1; CDHE; cell adhesion molecule; cell-CAM 120/80; ECAD; E-cad; E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3; Ecadherin; E-cadherin; E-cadherin 1; E-cadherin precursor; Epithelial cadherin; hab; half baked; LCAM; L-CAM; Um; UVO; Uvomorulin |
| Show More |